# Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects

> **NCT02936154** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06650833
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02936154
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02936154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02936154, "Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02936154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*